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Purpose: To report a case of advanced childhood glaucoma secondary to congenital ectropion uveae (CEU).
Case Report: The patient was a seven-year-old boy with unilateral glaucoma secondary to CEU and facial
asymmetry, mild unilateral ptosis, and proptosis in the left eye. The intraocular pressure (IOP) was 28 mmHg
and cup-to-disc ratio was 0.8 in the left eye. After starting glaucomamedication, IOP decreased to 21 mmHg.
In view of the uncontrolled IOP with medication and high cup-to-disc ratio and increased axial length of the
left eye, mitomycin-C (MMC)-augmented trabeculectomy was planned. Despite sub-tenon MMC injection
and bleb needling, the bleb failed after six months, and we had to perform a shunt procedure to control the
IOP.
Conclusion: Although CEU is rare, ophthalmologists should be familiar with this syndrome because of the
high frequency of glaucoma and its challenging management during childhood.
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INTRODUCTION
Ectropion uveae (EU) is defined as the presence
of iris pigment epithelium on the anterior surface
of the iris. Although EU is usually acquired, it
may occur as an isolated congenital anomaly or
in association with systemic diseases such as
neurofibromatosis.
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The most important complication of EU is glau-
coma, and its diagnosis and treatment are chal-
lenging during childhood because the intraocular
pressure (IOP) cannot be easily measured in a
crying toddler under routine settings, and signif-
icant damage may have already occurred by the
time of presentation. Hence, early detection, close
monitoring, and prompt treatment aremandatory to
safeguard lifelong vision of the child.
We report a case of glaucoma secondary to EU
and its management, along with a literature review.
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Figure 1. General appearance of the patient. Mild ptosis and
facial hemihypertrophy is seen.
CASE REPORT
A seven-year-old boy was referred to glaucoma
service for mild ptosis and gradual decrease in the
left eye vision.
He had facial asymmetry, with left hemifacial
hypertrophy and moderate ptosis and proptosis
of the left eye [Figure 1]. There was no history of
any medical or surgical intervention; family history
was unremarkable. Best-corrected visual acuity
were 20/20 and 20/30 in right and left eyes,
respectively. Full cycloplegic refraction was +1.75
diopters in the right eye and −3.5 diopters in the
left eye. Relative afferent pupillary defect was +1
in the left eye. There was 2 mm ptosis in the left
eye with normal levator palpebrae function. Hertel
exophthalmometry measurements were 14 and 21
mm with bar reading of 107 mm. The axial length
was 22.21 and 24.51 mm in the right and left eyes,
respectively. Extraocular muscle movement was
normal.
On slit lamp examination, the cornea was clear
and the anterior chamber (AC) depth was normal.
The iris was cryptless and there was a band
of hyperpigmentation at the margin of the pupil
consistent with EU [Figure 2]. Gonioscopy showed
anterior iris insertion and angle dysgenesis. Since
EU may be associated with systemic disorders, the
Figure 2. Slit lamp view shows ectropion uvea in left eye. Right
eye is normal.
whole body was examined carefully to detect any
remarkable signs of probable associated diseases.
Skin examination was normal, and there was no
café-au-lait spot or any other sign of neurofi-
bromatosis. Dental examination was also normal.
His height and weight measurements were within
normal limits for his age. His mental and intellectual
abilities were age-appropriate.
IOP was 13 and 28 mmHg without medication in
the right and left eyes, respectively. After starting
three glaucoma medications for the left eye, IOP
decreased to 21 mmHg. Cup-to-disc ratio was 0.2
and 0.8 in the right and left eyes, respectively,
with significant rim loss in the left eye [Figure 3].
Horizontal corneal diameter was 12 and 12.5 mm,
and central corneal thickness was 578 and 589 𝜇m
in the right and left eye, respectively. Peripapillary
nerve fiber layer optical coherence tomography
(OCT) and perimetry were normal in the right
eye, but in the left eye there was severe nerve
fiber layer loss in all quadrants in peripapillary
OCT and a double arcuate scotoma in perimetry
[Figure 4]. Axial and coronal orbital computerized
tomography (CT) scan showed left proptosis and
axial elongation of the left globe [Figure 5].
Due to asymmetric corneal diameter and
antimetropia, the clinical impression was that the
glaucoma in this patient was of early onset and
has been missed; hence, prompt intervention was
crucial. The patient was planned for Mitomycin-C
(MMC)-augmented trabeculectomy, which was
performed without complications. At the one-
month postoperative examination, IOP was 17
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Figure 3. Fundus photograph shows advanced cupping of left
optic disc.
mmHg without medication, and the bleb was
moderately vascularized and shallow [Figure 6].
Although subtenon MMC was injected in the
superior fornix, the bleb failed after six months,
and IOP increased to 20 mmHg. Bleb needling
and MMC injection were not successful, and we
had to perform a shunt procedure to control the
IOP. Six months after the shunt procedure, IOP
was controlled with the timolol-dorzolamide fixed
combination.
DISCUSSION
Ectropion uveae is characterized by the presence
of iris pigmented epithelium on the anterior surface
of the iris. It can be acquired, associated with
systemic diseases, or can manifest itself as an
isolated congenital syndrome. Acquired EU may
be associated with any inflammatory, ischemic,
or neoplastic process involving the iris such as
neovascular glaucoma or iridocorneal endothelial
(ICE) syndrome. This type of ectropion is commonly
progressive. EU can be associated with systemic
diseases, such as: neurofibromatosis type 1 (NF1),
Prader-Willi syndrome, and Rieger syndrome.
Ritch et al reported eight patients with CEU and
glaucoma, of which three had NF1.[1] Morales et
al found glaucoma in 13 of 56 patients with NF1
with orbital involvement, and eight of these thirteen
cases had EU.[2] In another study, all five patients
with orbitofacial NF1 and glaucoma demonstrated
histopathological EU.[3] So, the presence of EU in a
neonate necessitates a workup for NF.[4] Isolated
CEU syndrome is usually unilateral and tends
to be non-progressive. It is characterized by iris
pigment hyperplasia onto the anterior surface of
the iris around the pupillary margin. In contrast to
acquired EU, the iris sphincter muscle and stroma
are not affected in CEU and are not everted on
histopathologic examination.[5]
The iris-pigmented epithelium hyperplasia is
thought to be induced by an embryological rem-
nant that fails to fully regress in the AC.[6] This
anomaly may be caused by a late developmental
arrest of neural crest tissue in utero.[5]
Typical clinical findings include a smooth and
cryptless iris surface, proliferation of iris pigment
epithelium onto the anterior surface of the iris, and
glaucoma. Gonioscopy typically reveals anterior
iris insertion, angle dysgenesis, and incomplete
formation of trabecular meshwork and Schlemm’s
canal,[1, 5, 6] which is the primary mechanism of
glaucoma in CEU.
Glaucoma is a frequent complication of CEU. In
one report, glaucoma occurred in seven of eight
cases,[1] and in another study, in nine of ten CEU
cases.[5] So, all patients with CEU should be evalu-
ated periodically to detect and treat glaucoma.[1, 5]
The affected eye may exhibit mild ptosis with good
levator function. This finding is most likely related
to the neural crest origin of Mueller’s muscle. In the
aforementioned study , ptosis was reported in one
of eight cases[1] and in six of ten cases with CEU.[5]
Our patient also had antimetropia in cycloplegic
refraction because of greater axial length in the
left eye. There was combined pseudo and true
proptosis, because the amount of proptosis of the
left eye on Hertel exophthalmometry was greater
than the axial length difference, and hemifacial
hypertrophy seemed to play a role in proptosis.
This finding also presented in case 1 of a study by
Bansal et al,[7] who reported 6 mm proptosis and
2.2mmdifference in axial length. Although they did
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Figure 4. Perimetry shows double arcuate scotoma in left eye.
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Figure 5. Axial computerized tomography (CT) scan shows left
proptosis and different globe size.
Figure 6. Slit lamp photograph one month after trabeculec-
tomy. The bleb is shallow and moderately vascularized.
not mention combined mechanism proptosis, the
report was similar to the present study.
In the approach to a patient with CEU and glau-
coma, we should consider diseases that commonly
mimic it, such as Axenfeld-Rieger syndrome (ARS),
iridocorneal endothelial (ICE) syndrome, and NF1.
In ARS, the findings include a high iris insertion,
angle dysgenesis, EU, and glaucoma. However,
the syndrome can be distinguished from CEU
using other clinical findings such as posterior
embryotoxon, corectopia, or polycoria, and facial
abnormalities such as maxillary hypoplasia and
dental defects.[8] ICE syndrome is an acquired
condition with glaucoma and EU. ICE syndrome
predominantly affects middle-aged women, and its
occurrence in children is rare.[9]
The treatment of glaucoma in patients with
CEU usually requires surgery, although medical
management should be attempted initially. Effec-
tive surgical interventions for CEU-associated glau-
coma differ from the techniques used in primary
congenital glaucoma, and the success rate is much
lower, presumably due to severe angle dysgenesis
in this disorder. Glaucoma filtration surgery or a
shunt procedure may be necessary.[8, 10] In one
study, a total of six goniotomies in three patients
with glaucoma associated with CEU did not control
IOP, and they finally required trabeculectomy.[5]
Early failure of trabeculectomy in our patient might
suggest prompt consideration of a shunt procedure
in CEU-associated patients, when IOP is not con-
trolled with medical treatment.
In conclusion, although CEU is a rare syndrome,
it is associated with systemic diseases and high
frequency of glaucoma and its management in
children is challenging. Hence, ophthalmologists
should be familiar with this rare syndrome to
prevent irreversible vision loss.
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